Loading...
Asthmatic patients undergoing endotracheal intubation often develop bronchospasm. Intravenous lidocaine is recommended to prevent this reaction, but studies have been conducted only in animals or in human beings not undergoing general anesthesia and tracheal intubation. To assess the efficacy of lidocaine and albuterol in preventing intubation-induced bronchospasm, researchers in Boston randomized 60 patients to receive either lidocaine (1.5 mg/kg) or placebo intravenously 3 minutes before intubation and 50 patients to receive either 4 puffs of inhaled albuterol or placebo 15 to 20 minutes before intubation. All patients received anesthesia consisting of midazolam, propofol, fentanyl, vecuronium, and nitrous oxide.
Measurements of lower pulm…